As an advanced registered nurse, discuss your future role in advocating for equitable population health services and policies.
As an advanced registered nurse, discuss your future role in advocating for equitable population health services and policies.
Topic 8 DQ 2
Assessment Description
As an advanced registered nurse, discuss your future role in advocating for equitable population health services and policies. Do you anticipate any challenges or barriers to “population advocacy”? How would you meet these challenges?
ORDER A CUSTOMIZED, PLAGIARISM-FREE PAPER HERE
Good News For Our New customers. We can write this assignment for you and pay after Delivery. Our Top -rated medical writers will comprehensively review instructions , synthesis external evidence sources(Scholarly) and customize a quality assignment for you. We will also attach a copy of plagiarism report alongside and AI report. Feel free to chat Us
Role of Translational Research
Translational research is integral in transforming scientific research findings into evidence-based practices and interventions to benefit the general population. To advance equitable access to healthcare, there is a need to integrate special and underserved populations such as ethnic minorities throughout the translational research process (Hoyo et al., 2022). This will ensure equitable expedited implementation of targeted research-based health practices across diverse populations (Yousefi Nooraie et al., 2020). This requires appropriate actionable strategies tailored to health equity.
Various studies have been carried out to explore health inequities. However, sustainable frameworks to effectively address this issue are still inadequate. Translational research studies can successfully address healthcare inequities through comprehensive community engagement, cultural and contextual adaptation, and a focus on healthcare equity implementation policies and guidelines (Yousefi Nooraie et al., 2020). Training and capacity building through innovative means to improve translational research resilience on access to healthcare and preventive services also enhance the quality and efficiency of the implementation process.
The Health Care Improvement Act is a bill that was introduced in February 2021 and is still undergoing the legislative process. This bill aims to modify the Patient Protection and Affordable Care Act to further expand healthcare coverage and decrease healthcare costs. The existing mandates in the Affordable Care Act include the creation of competition and alternative marketplaces, the provision of subsidies to low-income consumers, and the expansion of Medicaid eligibility among others (McIntyre et al., 2019). The Health Care Improvement Act intends to make adjustments such as increasing premium assistance based on household income, developing a public health insurance alternative, giving authority to the federal government to negotiate the price of prescription drugs, adequate reimbursement of rural health providers, provision of incentives to fosters Medicaid expansion by states. If enacted, this bill will lead to improved access to quality and affordable healthcare and reduce health disparities.
References
Hoyo, V., Shah, R. C., Dave, G., & Volkov, B. B. (2022). Integrating special and underserved populations in translational research: Environmental scan of adaptive capacity and preparedness of Clinical and Translational Science Award (CTSA) program hubs. Journal of Clinical and Translational Science, 6(1). https://doi.org/10.1017/cts.2022.414
McIntyre, A., & Song, Z. (2019). The US Affordable Care Act: Reflections and directions at the close of a decade. Plos Medicine, 16(2). https://doi.org/10.1371/journal.pmed.1002752
Yousefi Nooraie, R., Kwan, B. M., Cohn, E., AuYoung, M., Clarke Roberts, M., Adsul, P., & Shelton, R. C. (2020). Advancing Health Equity through CTSA programs: Opportunities for interaction between health equity, dissemination and implementation, and Translational science. Journal of Clinical and Translational Science, 4(3), 168–175. https://doi.org/10.1017/cts.2020.10